[January 11, 2025] – Cornerstone Robotics (the “Company”), a leading innovator in surgical robotics, announces that it has successfully raised over US$70 million in Series C financing. This round of financing was led by EQT with participation from Qiming Venture Partners, Alpha JWC Ventures, The Innovation and Technology Venture Fund Corporation, eGarden Ventures, CTS Funds, K2VC, Long-Z Capital, and Lilly Asia Ventures. The financial advisor to the Company is UBS. This round of financing will accelerate the Company’s efforts in developing new surgical robotics products, conducting clinical trials, obtaining regulatory approvals, and promoting global adoption.
This round of financing attracted several new strategic investors, such as EQT, one of the largest private equity firms in Europe, and Alpha JWC Ventures, a leading venture capital firm in Southeast Asia. EQT and Alpha JWC Ventures will play a key role as Cornerstone Robotics expands into the European and Southeast Asian markets. As a company based in Hong Kong and the Greater Bay Area, the Company also received support from The Innovation and Technology Venture Fund in Hong Kong. The endorsement from these investors is a vote of confidence for Cornerstone Robotics’ product innovation and global commercialization capabilities.
“Alpha JWC Ventures is excited to partner with Cornerstone Robotics in their journey to expand into Southeast Asia. We believe their innovative approach to surgical robotics aligns with the growing needs and opportunities in the healthcare sector. We are committed to supporting their growth and success to bring the highest standards of healthcare in the region.” -Jefrey Joe, General Partner Alpha JWC Ventures
Since its establishment in September 2019, Cornerstone Robotics has been on a mission to revolutionize healthcare by making advanced surgical systems accessible to patients worldwide. The company’s vision drives continuous innovation in developing cutting-edge technologies for various surgical specialties.
A significant achievement came in September 2024 when Cornerstone Robotics reached a crucial milestone – obtaining NMPA (National Medical Products Administration) approval in China for “Sentire”, its pioneering Endoscopic Surgical System.
Through in-house R&D and vertical supply chain integration, Cornerstone Robotics delivers high-quality performance at competitive prices. This approach has led to partnerships with leading medical centers across mainland China, Hong Kong, and Europe. The company’s successful clinical trials in multiple specialties have created a solid foundation for international expansion and growth.
Professor Samuel Au, founder and CEO of Cornerstone Robotics, stated, “2024 is a pivotal milestone in the history of Cornerstone Robotics. We are deeply grateful to our shareholders for their trust and support. This milestone is not only a recognition of our team’s efforts in translating surgical robotics innovations into practical applications but also a testament to our commitment to long-term, high-quality development. ‘Building the cornerstone of surgical robotics industry’ has been our aspiration since we began in 2019. After five years of efforts, we have achieved independent R&D and manufacturing, also received recognition from the NMPA this year. Moving forward, our team will continue to innovate, expand global markets, advance international certifications, and collaborate with more partners to create value for the intelligent healthcare industry and contribute to a better future for humanity.”
